超研股份 reported revenue of ¥0.15B for the period ended 2026-06-30, -18.9% year on year. Net income was ¥0.03B, a 18.2% net margin on a 67.0% gross margin. The largest revenue line is 医用超声 at 55% of the total. Free cash flow for the period was ¥0.01B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.15B | -18.9% |
| Gross profit | ¥0.10B | — |
| Operating income | ¥0.03B | — |
| Net income | ¥0.03B | -60.4% |
| Gross margin | 67.0% | Net margin 18.2% |
| Revenue Q/Q | +24.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| 医用超声 | ¥0.08B | 55.5% |
| 工业超声 | ¥0.04B | 23.9% |
| X射线 | ¥0.02B | 11.1% |
| 配附件 | ¥0.01B | 8.0% |
| 其他(补充) | ¥0.00B | 1.4% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.05B | 33.0% |
| R&D | ¥0.02B | 14.8% |
| SG&A | ¥0.04B | 26.9% |
| Tax & other | ¥0.00B | 2.6% |
| Item | Amount |
|---|---|
| Total assets | ¥1.43B |
| Total liabilities | ¥0.11B |
| Shareholders' equity | ¥1.32B |
| Equity / assets | 92.4% |
| Operating cash flow | ¥0.01B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥0.01B |
| Cash conversion (OCF / net income) | 164% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
乔锋智能 ・ 绿联科技 ・ 富特科技 ・ 博实结 ・ 山大电力 ・ 珂玛科技 ・ 新铝时代 ・ 浙江华业 ・ 博苑新材 ・ 长联科技 ・ 英思特 ・ 苏州天脉
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies